NL-OMON36525已完成不适用
Biomarker study; study to identify biomarkers for protein intake, a randomized, fully controlled feeding study - Biomarker Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age 18-40 years
- •BMI between 18.5 and 30 kg/m2
- •Healthy (As judged by the participant)
- •For women: using oral contraceptives
- •Written informed consent obtained
排除标准
- •Unusual dietary patterns, including high alcohol intakes (>= 2 glasses/day) and a vegetarian diet
- •Usage of an energy restricted diet during the last two months
- •Weight loss or weight gain of 5 kg or more during the last two months
- •Any chronic disease
- •Usage of any prescribed medication except for oral contraceptives
- •For women: pregnant or lactating
- •For women: Unwilling to use oral contraceptives for consecutively for at least the total study duration
- •Liver function parameters (ALAT, ASAT, and γ-GT) and renal function parameters (Serum creatinin) outside the normal range
研究者
相似试验
招募中
不适用
An observational study to determine biomarkers for prognosis of lung lesions in patients with polymyositis/dermatomyositis complicated by interstitial lung diseasePolymyositis/dermatomyositis complicated with interstitial lung disease (PM/DM-ILD)JPRN-UMIN000046198agasaki University125
尚未招募
不适用
Biomarker study for postoperative AKI of Emergency surgeryAcute abdomenJPRN-UMIN000037653St marianna University School of Medicine150
尚未招募
不适用
Biomarker signature discovery study to determine acute bacterial respiratory tract infection.Respiratory tract infectionNL-OMON56538evels Diagnostics300
已完成
Unknown
Whole genome analysis and gene expression profiling using peripheral blood cells to establish a new method for evaluation of medical diseases.Type 2 diabetes, hypertension, dyslipidemia, obesity, etc.JPRN-UMIN000051647Kanazawa university200
招募中
不适用
A biomarker assessment study to investigate the influence of high-frequency chest wall oscillations on the clearance of cerebrospinal fluid biomarkersNL-OMON51372Centre for Human Drug Research34